Mayne Pharma Group Limited (OTCMKTS:MAYNF – Get Rating) was the target of a significant increase in short interest during the month of December. As of December 30th, there was short interest totalling 1,372,200 shares, an increase of 2,081.6% from the December 15th total of 62,900 shares. Based on an average daily volume of 347,700 shares, the short-interest ratio is currently 3.9 days.
Mayne Pharma Group Price Performance
MAYNF stock remained flat at $0.15 on Tuesday. 300 shares of the company traded hands, compared to its average volume of 2,325. Mayne Pharma Group has a fifty-two week low of $0.12 and a fifty-two week high of $0.29. The stock's fifty day moving average is $0.16 and its two-hundred day moving average is $0.19.
Get
Mayne Pharma Group alerts:
Mayne Pharma Group shares are going to reverse split before the market opens on Wednesday, January 18th. The 1-20 reverse split was announced on Wednesday, January 18th. The number of shares owned by shareholders will be adjusted after the market closes on Wednesday, January 18th.
Mayne Pharma Group Company Profile
(Get Rating)
Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe and Asia. The company operates through four segments: Metrics Contract Services, International, Branded Products, and Portfolio Products.
Read More
- Get a free copy of the StockNews.com research report on Mayne Pharma Group (MAYNF)
- United Airlines Soars Ahead of Earnings...Time to Deplane?
- Is Dividend King PPG Industries A Buy Before Earnings?
- Shocking New Documentary Exposes The Two Men Destroying America
- 3 Dividend Stocks For Passive Income
- UnitedHealth Group Stock: Is This The Bottom?
Receive News & Ratings for Mayne Pharma Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mayne Pharma Group and related companies with MarketBeat.com's FREE daily email newsletter.
梅恩製藥集團有限公司(場外交易市場代碼:MAYNF-GET Rating)是空頭股數12月份大幅增長的目標。截至12月30日,空頭股數共有137.22萬股,比12月15日的6.29萬股增加了2081.6%。以日均成交量347,700股計算,目前短息比率為3.9天。
Mayne Pharma集團價格表現
週二,MAYNF的股價持平於0.15美元。該公司300股易手,而其平均成交量為2325股。Mayne Pharma Group的股價為0.12美元,為52周低點,52周高點為0.29美元。該股的50日移動均線切入位為0.16美元,200日移動均線切入位為0.19美元。
到達
梅恩製藥集團警報:
梅恩製藥集團的股票將在1月18日星期三開盤前進行反向拆分。1比20的反向拆分是在1月18日星期三宣佈的。股東持股數量將在1月18日(週三)收盤後進行調整。
梅恩製藥集團公司簡介
(獲取評級)
梅恩製藥集團有限公司是一家專業製藥公司,在澳大利亞、紐西蘭、美國、加拿大、歐洲和亞洲製造和銷售品牌和仿製藥產品。該公司通過四個部門運營:公制合同服務、國際、品牌產品和投資組合產品。
閱讀更多內容
- 免費獲取StockNews.com關於Mayne Pharma Group(MAYNF)的研究報告
- 美國聯合航空公司盈利前飆升...是時候下機了?
- 股息王PPG Industries是在盈利之前買入嗎?
- 令人震驚的新紀錄片揭露了兩個摧毀美國的男人
- 3用於被動收益的股利股票
- UnitedHealth Group股票:這是底部嗎?
接受Mayne Pharma Group Daily的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Mayne Pharma Group和相關公司的最新新聞和分析師評級的每日簡要摘要。